Sotorasib in KRASG12C mutated lung cance Reply

被引：0
|
作者：
Paz-Ares, Luis [1 ]
Mehta, Bhakti [3 ]
Wang, Yang [3 ]
Obiozor, Cynthia [3 ]
Waterhouse, David [2 ]
de Langen, Adrianus Johannes [4 ]
机构：
[1] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid 28041, Spain
[2] Oncol Hematol Care, Cincinnati, OH USA
[3] Amgen Inc, Thousand Oaks, CA USA
[4] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
LANCET | 2024年 / 403卷 / 10422期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [21] PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib
    Chan, Chien-Hui
    Chiou, Li-Wen
    Lee, Tsai-Yu
    Liu, Yun-Ru
    Hsieh, Tsung-Han
    Yang, Ching-Yao
    Jeng, Yung-Ming
    BRITISH JOURNAL OF CANCER, 2023, 128 (01) : 148 - 159
  • [22] Cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRASG12C mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland
    El Saadany, T.
    Lupatsch, J.
    Mark, M.
    Mehra, T.
    Schwenkglenks, M.
    von Moos, R.
    SWISS MEDICAL WEEKLY, 2023, 153 : 56S - 56S
  • [23] Validation of an LC-MS/MS method for the determination of sotorasib, a KRASG12C inhibitor, in human plasma
    Wong, Philip
    Akrami, Anna
    Houk, Brett
    Vuu, Irene
    James, Christopher A.
    BIOANALYSIS, 2022, 14 (19) : 1281 - 1292
  • [24] PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib
    Chien-Hui Chan
    Li-Wen Chiou
    Tsai-Yu Lee
    Yun-Ru Liu
    Tsung-Han Hsieh
    Ching-Yao Yang
    Yung-Ming Jeng
    British Journal of Cancer, 2023, 128 : 148 - 159
  • [25] Resistance looms for KRASG12C inhibitors
    Aaron N. Hata
    Alice T. Shaw
    Nature Medicine, 2020, 26 : 169 - 170
  • [26] Sotorasib inhibits ubiquitination degradation of TXNIP and suppresses glucose metabolism in KRASG12C mutant bladder cancer
    Zhang, Zhi-Rong
    Liu, Min-Qi
    Ji, Yang
    Xiao, Di
    Wang, Wei-Fan
    Zhou, Xiao-Chen
    Wang, Ling-Hui
    Li, Duo
    Zou, Hui
    Yang, Xiao-Ping
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (11):
  • [27] TUSC2 gene therapy in KRASG12C mutant NSCLC overcomes acquired resistance to sotorasib
    Meraz, I.
    Majidi, M.
    Gao, L.
    Ren, C.
    Wu, S.
    Song, R.
    Meng, F.
    Xu, Y.
    Wang, Q.
    Xi, Y.
    Wang, J.
    Jung, S. Y.
    Shpall, E.
    Roth, J. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S145 - S145
  • [28] The Effective Targeting of KRASG12C Elusiveness
    Elez, Filiation Elena
    Tabernero, Josep
    CANCER CELL, 2020, 38 (06) : 785 - 787
  • [29] KRASG12C inhibitor: combing for combination
    Chakraborty, Atanu
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (06) : 2691 - 2701
  • [30] Progress on Covalent Inhibition of KRASG12C
    Westover, Kenneth D.
    Jaenne, Pasi A.
    Gray, Nathanael S.
    CANCER DISCOVERY, 2016, 6 (03) : 233 - 234
12345